Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antibodies stage a comeback in cancer treatment.

× No keyword cloud information.

9 in total

Review 1. Anti-interleukin 6 receptor antibody treatment in rheumatic disease.

Authors: N Nishimoto; T Kishimoto; K Yoshizaki
Journal: Ann Rheum Dis Date: 2000-11 Impact factor: 19.103

2. Antitumor activity of anti-type IV collagenase monoclonal antibody and its lidamycin conjugate against colon carcinoma.

Authors: Liang Li; Yun-Hong Huang; Yi Li; Feng-Qiang Wang; Bo-Yang Shang; Yong-Su Zhen
Journal: World J Gastroenterol Date: 2005-08-07 Impact factor: 5.742

3. Molecular dynamics force probe simulations of antibody/antigen unbinding: entropic control and nonadditivity of unbinding forces.

Authors: B Heymann; H Grubmüller
Journal: Biophys J Date: 2001-09 Impact factor: 4.033

Review 4. Clinical studies in patients with Castleman's disease, Crohn's disease, and rheumatoid arthritis in Japan.

Authors: Norihiro Nishimoto
Journal: Clin Rev Allergy Immunol Date: 2005-06 Impact factor: 8.667

5. Antibody therapy for Adult T-cell leukemia-lymphoma.

Authors: Takashi Ishida; Ryuzo Ueda
Journal: Int J Hematol Date: 2011-10-13 Impact factor: 2.490

6. Pharmacokinetics of radioimmunotherapeutic agent of direct labeling mAb 188Re-HAb18.

Authors: Chao Lou; Zhi-Nan Chen; Hui-Jie Bian; Jie Li; Shou-Bo Zhou
Journal: World J Gastroenterol Date: 2002-02 Impact factor: 5.742

Review 7. Transgenic milk as a method for the production of recombinant antibodies.

Authors: D P Pollock; J P Kutzko; E Birck-Wilson; J L Williams; Y Echelard; H M Meade
Journal: J Immunol Methods Date: 1999-12-10 Impact factor: 2.303

8. p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells.

Authors: Shin-Hyung Park; Myeong-A Seong; Ho-Young Lee
Journal: Oncotarget Date: 2016-02-16

9. An anti-GD2 monoclonal antibody enhances apoptotic effects of anti-cancer drugs against small cell lung cancer cells via JNK (c-Jun terminal kinase) activation.

Authors: Shoko Yoshida; Haruhiko Kawaguchi; Shigeki Sato; Ryuzo Ueda; Koichi Furukawa
Journal: Jpn J Cancer Res Date: 2002-07

9 in total